US Patent Issued to THE METHODIST HOSPITAL SYSTEM on March 3 for "Cancer neoantigens and their utilities in cancer vaccines and TCR-based cancer immunotherapy" (American, Chinese Inventors)

ALEXANDRIA, Va., March 3 -- United States Patent no. 12,565,680, issued on March 3, was assigned to THE METHODIST HOSPITAL SYSTEM (Houston).

"Cancer neoantigens and their utilities in cancer vaccines and TCR-based cancer immunotherapy" was invented by Rongfu Wang (Houston), Yicheng Wang (Houston), Lili Zhang (Shanghai) and Chen Qian (Houston).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are compositions and methods for identifying neoantigens and using neoantigens in the use of treating cancer, as well as autoimmune diseases, where antigens causing tissue destruction."

The patent was filed on April 25, 2019, under Application No. 17/050,586.

*For further information, including images, charts and...